These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10684445)

  • 1. Efficacy and Safety of Nifedipine Coat-Core versus Amlodipine in Patients With Mild to Moderate Essential Hypertension: Comparison of 24-Hour Mean Ambulatory Diastolic Blood Pressure.
    Byyny RL; Shannon T; Schwartz LA; Rotolo C; Jungerwirth S
    J Cardiovasc Pharmacol Ther; 1997 Apr; 2(2):77-84. PubMed ID: 10684445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension. Hypertension Study Group.
    Zidek W; Spiecker C; Knaup G; Steindl L; Breuer HW
    Clin Ther; 1995; 17(4):686-700. PubMed ID: 8565032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of daily anti-hypertensive effects of amlodipine and nifedipine coat-core using ambulatory blood pressure monitoring - utility of "hypobaric curve" and "hypobaric area".
    Kuga K; Xu DZ; Ohtsuka M; Aonuma K; Lau AH; Watanabe Y; Ohtsuka K
    Clin Exp Hypertens; 2011; 33(4):231-9. PubMed ID: 21699449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group.
    Mac Carthy EP; Pettis PP; Gibson L; Schwartz L; Feig PU
    Clin Ther; 1993; 15(6):976-87. PubMed ID: 8111817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.
    Glasser SP; Jain A; Allenby KS; Shannon T; Pride K; Pettis PP; Schwartz LA; MacCarthy EP
    Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
    Defina LF; Bookstaver DA; Goldfinger MP; Coffey TA
    Ann Pharmacother; 1997; 31(7-8):819-22. PubMed ID: 9220037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': a randomised, double-blind comparative trial in Asian patients.
    Ongtengco I; Morales D; Sanderson J; Lu ZR; Beilin LJ; Burke V; Puddey IB; Tanomsup S; Dayi H; Rahardjo P; Zambahari DR; Chen CY; Soenarta AA; Buranakitjaroen P; Tan C; Soon TK; Wu DJ
    J Hum Hypertens; 2002 Nov; 16(11):805-13. PubMed ID: 12444542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group.
    Feig PU; Gibson L; Mac Carthy EP; Pettis PP; Schwartz L
    Clin Ther; 1993; 15(6):963-75. PubMed ID: 8111816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of amlodipine and nifedipine GITS during treatment and after missing two doses.
    Hernández RH; Armas-Hernández MJ; Chourio JA; Armas-Padilla MC; López L; Alvarez M; Pacheco B
    Blood Press Monit; 2001 Feb; 6(1):47-57. PubMed ID: 11248761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
    Chrysant SG; Marbury TC; Robinson TD
    J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension. Nifedipine Study Group.
    Glasser SP; Ripa SR; Allenby KS; Schwartz LA; Commins BM; Jungerwirth S
    Clin Ther; 1995; 17(2):296-312. PubMed ID: 7614530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amlodipine with enalapril therapy in moderate-severe essential hypertension.
    Jensen H; Garsdal P; Davies J
    J Hum Hypertens; 1990 Oct; 4(5):541-5. PubMed ID: 2149389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of amlodipine and captopril in hypertension based on 24-hour ambulatory monitoring.
    Lacourcière Y; Poirier L; Provencher P
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S20-3. PubMed ID: 7522283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.